Annual Shareholders Equity
$140.86 M
-$140.62 M-49.96%
December 31, 2022
Summary
- As of February 9, 2025, TCRR annual stockholders equity is $140.86 million, with the most recent change of -$140.62 million (-49.96%) on December 31, 2022.
- During the last 3 years, TCRR annual shareholders equity has fallen by -$19.59 million (-12.21%).
Performance
TCRR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$101.33 M
-$39.53 M-28.06%
March 31, 2023
Summary
- As of February 9, 2025, TCRR quarterly stockholders equity is $101.33 million, with the most recent change of -$39.53 million (-28.06%) on March 31, 2023.
- Over the past year, TCRR quarterly shareholders equity has dropped by -$153.99 million (-60.31%).
Performance
TCRR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
TCRR Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.0% | -60.3% |
| 3 y3 years | -12.2% | -30.9% |
| 5 y5 years | +635.1% | - |
TCRR Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.0% | at low | -64.0% | at low |
| 5 y | 5-year | -50.0% | at low | -71.0% | at low |
| alltime | all time | -50.0% | -160.8% | -71.0% | -184.6% |
TCR2 Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $101.33 M(-28.1%) |
| Dec 2022 | $140.86 M(-50.0%) | $140.86 M(-29.1%) |
| Sep 2022 | - | $198.55 M(-12.2%) |
| Jun 2022 | - | $226.26 M(-11.4%) |
| Mar 2022 | - | $255.32 M(-9.3%) |
| Dec 2021 | $281.48 M(+19.0%) | $281.48 M(-8.1%) |
| Sep 2021 | - | $306.27 M(-6.9%) |
| Jun 2021 | - | $328.89 M(-6.0%) |
| Mar 2021 | - | $349.75 M(+47.9%) |
| Dec 2020 | $236.55 M | $236.55 M(-6.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $252.36 M(+89.2%) |
| Jun 2020 | - | $133.41 M(-9.0%) |
| Mar 2020 | - | $146.59 M(-8.6%) |
| Dec 2019 | $160.45 M(-287.2%) | $160.45 M(-6.3%) |
| Sep 2019 | - | $171.15 M(-6.3%) |
| Jun 2019 | - | $182.64 M(-4.9%) |
| Mar 2019 | - | $192.05 M(-324.1%) |
| Dec 2018 | -$85.70 M(+225.5%) | -$85.70 M(-165.7%) |
| Sep 2018 | - | $130.46 M(-595.6%) |
| Dec 2017 | -$26.32 M(+121.5%) | -$26.32 M |
| Dec 2016 | -$11.88 M | - |
FAQ
- What is TCR2 Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for TCR2 Therapeutics?
- What is TCR2 Therapeutics annual shareholders equity year-on-year change?
- What is TCR2 Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for TCR2 Therapeutics?
- What is TCR2 Therapeutics quarterly shareholders equity year-on-year change?
What is TCR2 Therapeutics annual stockholders equity?
The current annual shareholders equity of TCRR is $140.86 M
What is the all time high annual shareholders equity for TCR2 Therapeutics?
TCR2 Therapeutics all-time high annual stockholders equity is $281.48 M
What is TCR2 Therapeutics annual shareholders equity year-on-year change?
Over the past year, TCRR annual stockholders equity has changed by -$140.62 M (-49.96%)
What is TCR2 Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of TCRR is $101.33 M
What is the all time high quarterly shareholders equity for TCR2 Therapeutics?
TCR2 Therapeutics all-time high quarterly stockholders equity is $349.75 M
What is TCR2 Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, TCRR quarterly stockholders equity has changed by -$153.99 M (-60.31%)